Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer Corrigendum in /10.3892/mmr.2021.12359

Qin,Ling; Zhan,Zibo; Wei,Chunxue; Li,Xuemei; Zhang,Tongqin; Li,Jun

doi:10.3892/mmr.2021.12060

Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer

Corrigendum in 10.3892/mmr.2021.12359

Authors:
- Ling Qin
- Zibo Zhan
- Chunxue Wei
- Xuemei Li
- Tongqin Zhang
- Jun Li
View Affiliations

Affiliations: Department of Gastroenterology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610000, P.R. China
Published online on: April 1, 2021 https://doi.org/10.3892/mmr.2021.12060
Article Number: 421
Copyright: © Qin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In recent years, increasing evidence has confirmed that exosomal circular RNAs (circRNAs) serve a crucial role in the prognostic prediction and diagnosis of liver cancer (LC). The present study compared the expression patterns of exosomal circRNAs during transarterial chemoembolization (TACE). CircRNA sequencing analysis identified 390 differentially expressed circRNAs between the prior TACE and following the first TACE operation groups and 489 differentially expressed circRNAs between the prior to TACE and following the second TACE operation groups. Gene Ontology analysis of the differentially expressed circRNAs demonstrated that they were associated with fatty acid metabolism, receptor binding and membrane protein complexes. Kyoto Encyclopedia of Genes and Genomes pathway analysis predicted that protein digestion and absorption pathways were activated following TACE. A novel gene was screened out; hsa‑circRNA‑G004213 (circ‑G004213) was significantly upregulated following TACE (fold change >10, P<0.01). Further analysis found circ‑G004213 significantly increased the cisplatin sensitivity of HepG2 cells and positively associated with the prognosis of tumor‑bearing mice. Based on the potential downstream miRNAs and mRNAs, the circRNA‑miRNA‑mRNA network was constructed. It was demonstrated that circ‑G004213 regulated cisplatin resistance via the miR‑513b‑5p/PRPF39 axis. Finally, the present study confirmed that circ‑G004213 was positively associated with the prognosis of patients with LC following TACE. Therefore, circ‑G004213 may be used as an indicator for predicting the efficacy of TACE.

View Figures

View References

1	Lingiah VA, Niazi M, Olivo R, Paterno F, Guarrera JV and Pyrsopoulos NT: Liver transplantation beyond milan criteria. J Clin Transl Hepatol. 8:69–75. 2020. View Article : Google Scholar : PubMed/NCBI
2	Wu CC, Ho WL and Liu TJ: Hepatocellular carcinoma with adjacent organ extension: The enhancement of preoperative transcatheter arterial embolization and the results of surgical resection. Surg Today. 24:882–888. 1994. View Article : Google Scholar : PubMed/NCBI
3	Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, Kamel IR, Ghasebeh MA and Pawlik TM: Hepatocellular carcinoma: From diagnosis to treatment. Surg Oncol. 25:74–85. 2016. View Article : Google Scholar : PubMed/NCBI
4	Gu J, Zhang X, Cui R, Zhang J, Wang Z, Jia Y, Miao R, Dong Y, Ma X, Fan H, et al: Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization. Eur J Gastroenterol Hepatol. 31:836–844. 2019. View Article : Google Scholar : PubMed/NCBI
5	Loosen SH, Schulze-Hagen M, Leyh C, Benz F, Vucur M, Kuhl C, Trautwein C, Tacke F, Bruners P, Roderburg C and Luedde T: IL-6 and IL-8 serum levels predict tumor response and overall survival after TACE for primary and secondary hepatic malignancies. Int J Mol Sci. 19:17662018. View Article : Google Scholar
6	Daniele A, Divella R, Quaranta M, Mattioli V, Casamassima P, Paradiso A, Garrisi VM, Gadaleta CD, Gadaleta-Caldarola G, Savino E, et al: Clinical and prognostic role of circulating MMP-2 and its inhibitor TIMP-2 in HCC patients prior to and after trans-hepatic arterial chemo-embolization. Clin Biochem. 47:184–190. 2014. View Article : Google Scholar : PubMed/NCBI
7	Zhou L, Lv T, Zhang Q, Zhu Q, Zhan P, Zhu S, Zhang J and Song Y: The biology, function and clinical implications of exosomes in lung cancer. Cancer Lett. 407:84–92. 2017. View Article : Google Scholar : PubMed/NCBI
8	Shi X, Wang B, Feng X, Xu Y, Lu K and Sun M: circRNAs and exosomes: A mysterious frontier for human cancer. Mol Ther Nucleic Acids. 19:384–392. 2020. View Article : Google Scholar : PubMed/NCBI
9	Wan M, Ning B, Spiegel S, Lyon CJ and Hu TY: Tumor-derived exosomes (TDEs): How to avoid the sting in the tail? Med Res Rev. 40:385–412. 2020. View Article : Google Scholar : PubMed/NCBI
10	Han Q, Zhao H, Jiang Y, Yin C and Zhang J: HCC-derived exosomes: Critical player and target for cancer immune escape. Cells. 8:5582019. View Article : Google Scholar
11	Abudoureyimu M, Zhou H, Zhi Y, Wang T, Feng B, Wang R and Chu X: Recent progress in the emerging role of exosome in hepatocellular carcinoma. Cell Prolif. 52:e125412019. View Article : Google Scholar : PubMed/NCBI
12	Sarnow P and Sagan SM: Unraveling the mysterious interactions between hepatitis C virus RNA and liver-specific microRNA-122. Annu Rev Virol. 3:309–332. 2016. View Article : Google Scholar : PubMed/NCBI
13	Li B, Mao R, Liu C, Zhang W, Tang Y and Guo Z: LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells. Life Sci. 197:122–129. 2018. View Article : Google Scholar : PubMed/NCBI
14	Liu J, Fan L, Yu H, Zhang J, He Y, Feng D, Wang F, Li X, Liu Q, Li Y, et al: Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages. Hepatology. 70:241–258. 2019.PubMed/NCBI
15	Huang XY, Huang ZL, Huang J, Xu B, Huang XY, Xu YH, Zhou J and Tang ZY: Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res. 39:202020. View Article : Google Scholar : PubMed/NCBI
16	Su Y, Lv X, Yin W, Zhou L, Hu Y, Zhou A and Qi F: CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY). 11:8182–8203. 2019.
17	Wang G, Liu W, Zou Y, Wang G, Deng Y, Luo J, Zhang Y, Li H, Zhang Q, Yang Y and Chen G: Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a-MET pathway. EBioMedicine. 40:432–445. 2019. View Article : Google Scholar : PubMed/NCBI
18	Zhang H, Deng T, Ge S, Liu Y, Bai M, Zhu K, Fan Q, Li J, Ning T, Tian F, et al: Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7. Oncogene. 38:2844–2859. 2019. View Article : Google Scholar : PubMed/NCBI
19	Wang X, Zhang X, Wang G, Wang L, Lin Y and Sun F: Hsa-miR-513b-5p suppresses cell proliferation and promotes P53 expression by targeting IRF2 in testicular embryonal carcinoma cells. Gene. 626:344–353. 2017. View Article : Google Scholar : PubMed/NCBI
20	Lin W, Ye H, You K and Chen L: Up-regulation of circ_LARP4 suppresses cell proliferation and migration in ovarian cancer by regulating miR-513b-5p/LARP4 axis. Cancer Cell Int. 20:52020. View Article : Google Scholar : PubMed/NCBI
21	Stark AL, Delaney SM, Wheeler HE, Im HK and Dolan ME: Functional consequences of PRPF39 on distant genes and cisplatin sensitivity. Hum Mol Genet. 21:4348–4355. 2012. View Article : Google Scholar : PubMed/NCBI
22	National Health and Family Planning Commission, . Notice of general office of national health and family planning commission on printing and issuing standards for diagnosis and treatment of primary liver cancer (2017 edition). http://www.nhfpc.gov.cn/yzygj/s7659/201706/80abf02a86c048fcd130e5e298f7aeee.shtmlJune 2–2017
23	Kim KM, Shim SG, Sinn DH, Song JE, Kim BS and Kim HG: Child-Pugh, MELD, MELD-Na, and ALBI scores: Which liver function models best predicts prognosis for HCC patient with ascites? Scand J Gastroenterol. 55:951–957. 2020. View Article : Google Scholar : PubMed/NCBI
24	Li K, Gao B, Li J, Chen H, Li Y, Wei Y, Gong D, Gao J, Zhang J, Tan W, et al: ZNF32 protects against oxidative stress-induced apoptosis by modulation C1QBP transcription. Oncotarget. 6:38107–38126. 2015. View Article : Google Scholar : PubMed/NCBI
25	Li J, Ao J, Li K, Zhang J, Li Y, Zhang L, Wei Y, Gong D, Gao J, Tan W, et al: ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma. Cell Death Dis. 7:e24282016. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Wang H, Lu Z and Zhao X: Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer. J Hematol Oncol. 12:1332019. View Article : Google Scholar : PubMed/NCBI
28	He X, Yu J, Xiong L, Liu Y, Fan L, Li Y, Chen B, Chen J and Xu X: Exosomes derived from liver cancer cells reprogram biological behaviors of LO2 cells by transferring Linc-ROR. Gene. 719:1440442019. View Article : Google Scholar : PubMed/NCBI
29	Wang G, Zhao W, Wang H, Qiu G, Jiang Z, Wei G and Li X: Exosomal miR-744 inhibits proliferation and sorafenib chemoresistance in hepatocellular carcinoma by targeting PAX2. Med Sci Monit. 25:7209–7217. 2019. View Article : Google Scholar : PubMed/NCBI
30	Wakana H, Kono H, Fukushima H, Nakata Y, Akazawa Y, Maruyama S, Hagio K, Fujii H and Ichikawa D: Effects of medium-chain triglycerides administration in chemically-induced carcinogenesis in mice. Anticancer Res. 39:6653–6660. 2019. View Article : Google Scholar : PubMed/NCBI
31	Wang H, Lu J, Dolezal J, Kulkarni S, Zhang W, Chen A, Gorka J, Mandel JA and Prochownik EV: Inhibition of hepatocellular carcinoma by metabolic normalization. PLoS One. 14:e02181862019. View Article : Google Scholar : PubMed/NCBI
32	Sakurai Y, Kubota N, Takamoto I, Obata A, Iwamoto M, Hayashi T, Aihara M, Kubota T, Nishihara H and Kadowaki T: Role of insulin receptor substrates in the progression of hepatocellular carcinoma. Sci Rep. 7:53872017. View Article : Google Scholar : PubMed/NCBI
33	Chen J, Rajasekaran M, Xia H, Zhang X, Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BK, Ooi LL, et al: The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Gut. 65:1522–1534. 2016. View Article : Google Scholar : PubMed/NCBI
34	Hou C, Guo D, Yu X, Wang S and Liu T: TMT-based proteomics analysis of the anti-hepatocellular carcinoma effect of combined dihydroartemisinin and sorafenib. Biomed Pharmacother. 126:1098622020. View Article : Google Scholar : PubMed/NCBI
35	Cao D, Wang Y, Li D and Wang L: Reconstruction and analysis of the differentially expressed IncRNA-miRNA-mRNA network based on competitive endogenous RNA in hepatocellular carcinoma. Crit Rev Eukaryot Gene Expr. 29:539–549. 2019. View Article : Google Scholar : PubMed/NCBI
36	Zhou ZR, Liu M, Lu HR, Li YF, Liang SX and Zhang CY: Validation of different staging systems for hepatocellular carcinoma in a cohort of 249 patients undergoing radiotherapy. Oncotarget. 8:46523–46531. 2017. View Article : Google Scholar : PubMed/NCBI
37	de Freitas LB, Longo L, Santos D, Grivicich I and Álvares-da-Silva MR: Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population. World J Hepatol. 11:678–688. 2019. View Article : Google Scholar : PubMed/NCBI
38	Bird TG, Dimitropoulou P, Turner RM, Jenks SJ, Cusack P, Hey S, Blunsum A, Kelly S, Sturgeon C, Hayes PC and Bird SM: Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection. PLoS One. 11:e01568012016. View Article : Google Scholar : PubMed/NCBI
39	Lian YF, Li SS, Huang YL, Wei H, Chen DM, Wang JL and Huang YH: Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma. Biosci Rep. 38:BSR201811782018. View Article : Google Scholar : PubMed/NCBI
40	Lu SX, Zhang CZ, Luo RZ, Wang CH, Liu LL, Fu J, Zhang L, Wang H, Xie D and Yun JP: Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. Cancer Lett. 402:71–80. 2017. View Article : Google Scholar : PubMed/NCBI
41	Zhu P, Wang Y, He L, Huang G, Du Y, Zhang G, Yan X, Xia P, Ye B, Wang S, et al: ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells. J Clin Invest. 125:3795–3808. 2015. View Article : Google Scholar : PubMed/NCBI
42	Cho HK, Kim SY, Kyaw YY, Win AA, Koo SH, Kim HH and Cheong J: HBx induces the proliferation of hepatocellular carcinoma cells via AP1 over-expressed as a result of ER stress. Biochem J. 466:115–121. 2015. View Article : Google Scholar : PubMed/NCBI
43	Ying H, Xu Z, Chen M, Zhou S, Liang X and Cai X: Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins. Onco Targets Ther. 11:689–702. 2018. View Article : Google Scholar : PubMed/NCBI